Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Front Endocrinol (Lausanne). 2023 Nov 9;14:1260623. doi: 10.3389/fendo.2023.1260623. eCollection 2023.
Type 2 diabetes (T2D) is the leading cause of diabetes worldwide and is increasing rapidly, especially in youth. It accounts for most diabetes deaths in adults ≥20 years old in the Americas, with type 2 diabetes responsible for most of the disease burden. The incidence and burden of type 2 diabetes in adolescents and young adults have risen in recent decades globally. Countries with lower socioeconomic status had the highest incidence and burden, and females generally had higher mortality and disease burden than males at ages <30 years. Early diagnosis and management are crucial to delaying progression, but current diagnostic criteria based on glucose thresholds and glycated hemoglobin have limitations. Recent analyses show that prediabetes increases cancer risk. Better diagnostic criteria are urgently needed to identify high-risk individuals earlier. This article discusses the limitations of current criteria and explores alternative approaches and future research directions.
2 型糖尿病(T2D)是全球范围内糖尿病的主要病因,且其发病率正在迅速上升,尤其是在年轻人中。在美洲,20 岁及以上成年人中,大多数糖尿病死亡归因于 2 型糖尿病,且 2 型糖尿病是疾病负担的主要原因。近年来,青少年和年轻成年人中 2 型糖尿病的发病率和疾病负担呈上升趋势。社会经济地位较低的国家发病率和疾病负担最高,在年龄<30 岁时,女性的死亡率和疾病负担通常高于男性。早期诊断和管理对于延缓疾病进展至关重要,但目前基于血糖阈值和糖化血红蛋白的诊断标准存在局限性。最近的分析表明,糖尿病前期会增加癌症风险。因此,迫切需要更好的诊断标准来更早地识别高危人群。本文讨论了当前标准的局限性,并探讨了替代方法和未来的研究方向。